CD8A and non-small cell lung carcinoma: Studies have shown that improved outcomes correlate positively with CD8+ T cell infiltration in several types of tumors (12–14), including melanoma (15), non-small cell lung cancer (NSCLC) (16), breast cancer (17), and cervical cancer (18).